Professor Joris R. Vermeesch is a Full Professor of Molecular Cytogenetics and Genome Research at KU Leuven (Katholieke Universiteit Leuven), Belgium. He is a staff member of the Center for Human Genetics and serves as the Scientific Director of the Genomics Core Facility at KU Leuven. Internationally recognized for his pioneering contributions to preimplantation, prenatal, and postnatal genetic diagnosis, as well as cancer genomics, Prof. Vermeesch has been at the forefront of advancing genomic technologies for clinical and research applications. His research focuses on the development and translation of cutting-edge genomic methodologies, particularly in the detection of single-cell aneuploidy and the study of chromosomal instability. His work has provided critical insights into the mechanisms underlying chromosomal instability and structural rearrangements, particularly during early human development. Through innovative technologies, including single-cell arrays and massively parallel sequencing, his laboratory has identified novel phenomena associated with chromosomal instability in human embryos. Prof. Vermeesch has made significant contributions to the scientific community, with an extensive publication record exceeding 400 peer-reviewed papers and a Google Scholar H-index of 84. He is the founder of Cartagenia, a genomics diagnostics spin-off company, and has held numerous leadership roles, including past President of the Belgian Society of Human Genetics, Scientific Board Member of the European Cytogenetics Association, and elected Board Member of the International Society for Prenatal Diagnosis (ISPD). Currently, he serves as the President-Elect of the Preimplantation Genetic Diagnosis International Society (PGDIS).

Professor Darren Griffin received his BSc and DSc degrees from the University of Manchester and his PhD from University College London. After postdoctoral stints at Case Western Reserve University and the University of Cambridge, he landed his first academic post at Brunel University, before settling at the University of Kent, 20 years ago. He is a Fellow of the Royal College of Pathologists, the Royal Society of Biology, and the Royal Society of Arts and is President of the International Chromosome and Genome Society. A world leader in cytogenetics, he performed the first successful cytogenetic PGT and played a significant role in the development of Karyomapping, an approach he now applies to cattle and pigs. He has co-authored ~350 scientific publications, mainly on the cytogenetics of reproduction and evolution, recently providing insight into the karyotypes of dinosaurs. He is a prolific science communicator, a part time TV presenter and an enthusiastic proponent of interdisciplinary research endeavour. He has supervised over 45 PhD students to completion and his work appears consistently in the media. He has run a vibrant research group including a programme of externally supervised students and maintains commercial interests relating to the outcomes of research findings.

Dr. Ayman El-Hattab is a Professor at the College of Medicine, University of Sharjah; and he is heavily involved in research. He has conducted many clinical research projects, and he has more than 120 publications, several book chapters, and many presentations in scientific conferences. His research fields include chromosomal abnormalities, metabolic disorders, neurogenetic diseases, novel gene and syndrome discovery, and mitochondrial diseases. Professor Ayman El-Hattab has received several awards, and he was designated as one of the world’s top 2% scientists in the field of genetics by Stanford University, USA in the report published in October 2020.

Dr. Xiangwen Peng received his Ph.D. in genetics from Fudan University in Shanghai, China. He completed post-doc training in Dr Jiandong Liu Lab at University of North Carolina at Chapel Hill and Dr Patterson, Michaelas lab at the Medical College of Wisconsin. Now he is the director of the central laboratory of Changsha Maternal and Child Health Hospital at Hunan Normal University, China. Peng’s research interests include the molecular and cellular mechanisms of human birth defects, genetic diseases heart disease and child rehabilitation .He has published 16 papers.

Dr. Mosad Zineldin is a Professor at Faculty of Health and Life Sciences-Medicine and Optometry institution. Linnaeus University- Sweden. Grounder of ACRC (Academic Center for Research and Consultancy) in Sweden, He have a multidisciplinary background in Health Science, Phycology,community health, Psychiatry, Medical and Quality studies. Taught at Stockholm University for many years. He is supervisor of degree projects for medical students. Had leading positions at Linnaeus and Stockholm universities in Sweden. Editor in Chief and Associate Editor of several Psychology and Psychiatry international Journals. Wrote and published several books and over 100 articles in many different international journals. He has invented new concepts, models and theories related to medical and health sciences. His latest major research interests and publications are on Cognitive and Bran Reserve Interventions to reduce the risk of Dementia; Preventive medicine and Divorce on Physical and Mental Health; Brain Arteriovenous Malformations (BAVMs) and Endovascular Catheter Embolization; e-health and digitalization of medical and health education.

Prof. Davor Zeljezic, PhD, ERT works as a Scientific Advisor, tenure position, at the Institute for Medical Research and Occupational Health, Unit for Toxicology, Zagreb, Croatia. For last 25 years main field of his research has been genetic toxicology, methods applied being chromosomal aberrations analysis, micronucleus assay, alkaline and enzyme-modified comet assay, sister chromatid exchange test, fluorescent in situ hybridization (FISH) on metaphase chromosomes, micronucleus and comet assay. Beside genotoxicity evaluation in different cell culture models or animals determining the effect in different organs and tissues, he participated in epidemiological genotoxicity studies comprising populations occupationally exposed to various agents and studies aiming to define baseline level of genetic damage in general population. Genotoxicity assessments were mainly focused on effect of pesticides, mycotoxins, and dental materials. In 2017 he was recognized as European Registered Toxicologist (ERT) and certified. He has experience as a scientific and organizing committees’ member of 3 international and 4 domestic conferences, being a principal investigator of 2 domestic research projects, member of project proposals evaluation panels, member of the editorial board of the BioMed Research International and Toxics, guest editor of the special issue of the Water, expert at the European Chemicals Agency (ECHA), expert at the European Food Safety Authority (EFSA). He acted as the president of the Croatian branch of the EUROTOX's Register of certified toxicologists, certified as European Registered Toxicologist by Federation of European Toxicologists and European Societies of Toxicology EUROTOX, is a member of the Partner Experts Group for revision of the REACH regulation of European Commission in the field of mutagenicity/genotoxicity testing and endocrine disruption, member of the REACH Exposure Expert Group (REEG) of ECHA, member of the Croatian Toxicological Society, European Association for Cancer Research, European Cytogeneticists Association. Davor Zeljezic has published 126 peer-reviewed publications cited more than 2000 times by other authors, h-index 26.